Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

32.02B

Market cap32.02B

Price-Earnings ratio

12.85

Price-Earnings ratio12.85

Dividend yield

2.66%

Dividend yield2.66%

Average volume

7.40M

Average volume7.40M

High today

$77.90

High today$77.90

Low today

$74.87

Low today$74.87

Open price

$77.36

Open price$77.36

Volume

7.65M

Volume7.65M

52 Week high

$172.23

52 Week high$172.23

52 Week low

$72.38

52 Week low$72.38

Stock Snapshot

With a market cap of 32.02B, Zoetis(ZTS) trades at $76.07. The stock has a price-to-earnings ratio of 12.85 and currently yields dividends of 2.7%.

During the trading session on 2026-06-02, Zoetis(ZTS) shares reached a daily high of $77.90 and a low of $74.87. At a current price of $76.07, the stock is +1.6% higher than the low and still -2.3% under the high.

Trading activity shows a volume of 7.65M, compared to an average daily volume of 7.4M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $172.23 and a low of $72.38.

ZTS News

Simply Wall St 3d

Zoetis Lawsuit Puts Companion Animal Disclosures And Valuation Gap In Focus

Securities class action lawsuit filed against Zoetis (NYSE:ZTS) and certain executives alleging misleading statements about product safety and demand in the Com...

TipRanks 6d

Zoetis downgraded to Hold from Buy at Argus

Argus analyst Jasper Hellweg downgraded Zoetis (ZTS) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...

Simply Wall St 7d

Assessing Zoetis Valuation After Steep Share Price Weakness And Profitability Concerns

Advertisement Zoetis stock: recent performance and context Zoetis (ZTS) has drawn attention after a steep share price decline, with the stock down about 31% o...

Analyst ratings

59%

of 22 ratings

Buy

59.1%

Hold

40.9%

Sell

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.